Amniotic membrane as a cornerstone therapy for limbal stem cell deficiency, conjunctival cicatrization, and complex ocular surface failure.
The ocular surface — comprising the corneal epithelium, limbal zone, conjunctival epithelium, tear film, and accessory glands — functions as an integrated system. Disruption of any component can trigger a cascade of dysfunction that ultimately threatens vision.
Ocular surface disease (OSD) exists on a spectrum from mild (isolated dry eye) to severe (total surface failure following chemical burns or cicatricial conjunctivitis). Amniotic membrane plays a therapeutic role across this spectrum, with its importance growing in proportion to the severity of disease.
In complex OSD, particularly where the limbal stem cell niche is compromised, amniotic membrane often serves as a preparatory or adjunctive step before definitive stem cell transplantation — creating a more favorable environment for graft survival and integration.
Limbal stem cells (LSCs) reside in the palisades of Vogt at the corneoscleral junction and are responsible for continuous corneal epithelial renewal. LSCD — whether partial or total — results in conjunctivalization of the cornea, chronic epithelial instability, neovascularization, and vision loss.
Alkali injuries (most common), acid burns. Direct damage to the limbal niche causes acute and progressive LSC loss.
Cicatricial inflammation destroys the limbal microenvironment. One of the most common causes of bilateral total LSCD.
Chronic hypoxia and mechanical trauma from extended wear can cause partial, usually peripheral LSCD over years.
Congenital PAX6 mutation leads to progressive LSCD, keratopathy, and corneal opacification from early childhood.
Multiple conjunctival surgeries, mitomycin C exposure, and cryotherapy can damage the limbal niche iatrogenically.
Autoimmune subepithelial fibrosis progressively destroys conjunctiva, fornices, and eventually the limbal stem cell population.
Amniotic membrane supports LSCD management at multiple stages:
Acute: Suppress inflammation and protect surviving LSCs from further injury — particularly critical in chemical burns and SJS within the first 48–72 hours.
Preparatory: Create a hospitable stromal environment before limbal stem cell transplantation (LSCT), cultivated limbal epithelial transplantation (CLET), or simple limbal epithelial transplantation (SLET).
Carrier scaffold: AM is frequently used as the carrier substrate for ex vivo expanded limbal epithelial cells in CLET procedures, providing a biocompatible transplant vehicle.
Progressive conjunctival scarring — from conditions such as ocular cicatricial pemphigoid (OCP), SJS, trachoma, and radiation — leads to fornix foreshortening, symblepharon, entropion, trichiasis, and ultimately corneal keratinization.
Amniotic membrane plays a reconstructive role in restoring the fornices and conjunctival surface:
Several grading systems guide clinical decision-making in OSD. Understanding where a patient falls on these scales helps determine when amniotic membrane alone is sufficient vs. when more advanced reconstruction is required.
| Stage | Description | AM Role |
|---|---|---|
| Mild OSD | Isolated DED, mild PED, superficial punctate keratitis | Self-retained AM device; in-office application |
| Moderate OSD | Recurrent PEDs, partial LSCD, early cicatricial disease | Surgical AMT; may require repeat applications |
| Severe OSD | Total LSCD, deep ulcers, symblepharon, total surface failure | AM as adjunct/preparatory step before LSCT or keratoprosthesis |
| Acute Emergency | Active chemical burn, SJS within 2 weeks onset | Urgent multilayer AM; symblepharon ring technique |